Home > Insider Trading > Filing (0001209191-14-049771)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1393434	Ocular Therapeutix Inc	OCUL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614417	Amarpreet Sawhney	C/O Ocular Therapeutix, Inc. 36 Crosby Drive, Suite 101 Bedford MA 01730	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-07-30	23,357	$0.00	487,242	No	4	C	Direct
Common Stock	Acquisiton	2014-07-30	213,915	$0.00	846,377	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-07-30	16,075	$0.00	394,862	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-07-30	76,922	$13.00	471,784	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2014-07-30	320,836	$0.00	121,528	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-07-30	61,664	$0.00	23,357	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-07-30	243,902	$0.00	92,387	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-07-30	42,440	$0.00	16,075	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Direct
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A and Series C Preferred Stock converted into Common Stock on a 2.64-for-one basis upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The preferred stock had no expiration date.
The securities are directly held by Incept, LLC. The Reporting Person is a general partner of Incept, LLC. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
The securities are directly held by the Sangam Trust. The Reporting Person and his immediate family members are beneficiaries of the Sangam Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.